We recently discovered that an ECM immunomodulatory proteoglycan versican (VCAN) and its ADAMTS-protease proteolytic cleavage product versikine (Vkine) differentially accumulate in the TME of multiple myeloma [16] and colorectal cancers (CRC) [17]. The gene discussed is VCAN; the disease is plasma cell myeloma.